[Use of a 1:1 association of ampicillin and flucloxacillin in surgical patients (author's transl)].

Author: LucchettiV

Paper Details 
Original Abstract of the Article :
This clinical trial was designed to assess the validity of an association of equal parts of ampicillin and flucloxacillin in surgical patients; the product was administered by injection in daily doses of 2-3 grams. In a group of 20 patients the same product was used prophylactically against infectio...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://pubmed.ncbi.nlm.nih.gov/535108

データ提供:米国国立医学図書館(NLM)

A New Alliance in Surgical Infection Control: Ampicillin and Flucloxacillin

The fight against surgical infections is a constant battle, much like a camel facing the harsh conditions of the desert. This clinical trial explores the effectiveness of a combination of ampicillin and flucloxacillin in surgical patients. The researchers aimed to assess the efficacy of this combination in preventing and treating surgical infections. They found that this combination was effective in preventing infection in 85% of cases and also showed promise in treating urinary and biliary infections. However, the study also noted allergic cutaneous reactions in some patients.

A Promising New Combination

The study demonstrated the effectiveness of the ampicillin and flucloxacillin combination in both preventing and treating surgical infections. This finding provides a potential new option for managing surgical infections, offering hope for improved patient outcomes.

Navigating Potential Risks

The study also identified allergic cutaneous reactions as a potential side effect of this drug combination. It's important to remember that every individual reacts differently to medications, and this study highlights the importance of carefully monitoring patients for any adverse reactions. It's essential to discuss potential risks and benefits with your doctor before starting any new medication.

Dr.Camel's Conclusion

This clinical trial introduces a new approach to battling surgical infections, highlighting the potential benefits of combining ampicillin and flucloxacillin. This research is a testament to the relentless pursuit of improved patient care, even in the face of challenges. Just like a camel navigating a treacherous desert, we must always strive for progress and better solutions.

Date :
  1. Date Completed 1980-05-23
  2. Date Revised 2013-11-21
Further Info :

Pubmed ID

535108

DOI: Digital Object Identifier

535108

Related Literature

SNS
PICO Info
in preparation
Languages

Italian

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.